<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[phrma Resources | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/phrma.html]]></link>
	<description><![CDATA[White papers, case studies, business articles, and blog posts relating to phrma]]></description>
	<s:counts start="0" returned="20" found="53" />
	<language>en-us</language>
	<item>
		<title><![CDATA[PhRMA's New Clinical Trial Guidelines Leave Plenty of Room for Maneuver]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10004556/phrmas-new-clinical-trial-guidelines-leave-plenty-of-room-for-maneuver/]]></link>
		<description><![CDATA[Two cheers for PhRMA, which has produced a set of guidelines urging its members to conduct clinical trials in a more fair manner -- and to stop bribing doctors with fancy trips to the Caribbean. by Jim Edwards]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Thu, 01 Oct 2009 08:38:58 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/guideline.html"><![CDATA[Guideline]]></category>
		<category domain="http://resources.bnet.com/topic/clinical+trial.html"><![CDATA[Clinical Trial]]></category>
		<category domain="http://resources.bnet.com/topic/phrma.html"><![CDATA[PhRMA]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
	</item>
	<item>
		<title><![CDATA[Healthcare Industry Labors Mightily, Brings Forth a Mouse]]></title>
		<link><![CDATA[http://industry.bnet.com/healthcare/1000721/healthcare-industry-labors-mightily-brings-forth-a-turd/]]></link>
		<description><![CDATA[Three weeks ago, a coalition of health industry groups reportedly told President Obama they could cut $2 trillion in healthcare spending over 10 years. A few days later, the American Hospital Association and Americaâ€™s Health Insurance Plans appeared to be backpedaling, saying that cutting the annual spending growth rate by...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Mon, 01 Jun 2009 17:44:32 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/ahip.html"><![CDATA[AHIP]]></category>
		<category domain="http://resources.bnet.com/topic/benefits.html"><![CDATA[Benefits]]></category>
		<category domain="http://resources.bnet.com/topic/health+care.html"><![CDATA[Health Care]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/human+resources.html"><![CDATA[Human Resources]]></category>
		<category domain="http://resources.bnet.com/topic/ken+terry.html"><![CDATA[Ken Terry]]></category>
		<category domain="http://resources.bnet.com/topic/mouse.html"><![CDATA[Mouse]]></category>
		<category domain="http://resources.bnet.com/topic/phrma.html"><![CDATA[PHRMA]]></category>
		<category domain="http://resources.bnet.com/topic/vertical+industries.html"><![CDATA[Vertical Industries]]></category>
	</item>
	<item>
		<title><![CDATA[Lilly, Barr, AZ and Sepracor Were Generous to Sen. Hatch's Utah Charity]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10001220/lilly-barr-az-and-sepracor-were-generous-to-sen-hatchs-utah-charity/]]></link>
		<description><![CDATA[Five drug and device companies, plus their lobbyist, PhRMA, are all very, very concerned about the welfare of Utah families. So concerned they gave $172,400 to the Utah Family Foundation over the last few years.    By amazing coincidence, the foundation was founded by Sen. Orrin Hatch, who...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Mon, 02 Mar 2009 09:06:14 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/lobbyist.html"><![CDATA[Lobbyist]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
		<category domain="http://resources.bnet.com/topic/sepracor+inc..html"><![CDATA[Sepracor Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/utah.html"><![CDATA[Utah]]></category>
		<category domain="http://resources.bnet.com/topic/orrin+hatch.html"><![CDATA[Orrin Hatch]]></category>
		<category domain="http://resources.bnet.com/topic/phrma.html"><![CDATA[PhRMA]]></category>
		<category domain="http://resources.bnet.com/topic/washington+times.html"><![CDATA[Washington Times]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">SEPR</category>
		<category domain="tickers">SEPR</category>
	</item>
	<item>
		<title><![CDATA[PhRMA's New Drug Ad Rules Still Lack an Enforcement Mechanism]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/1000485/phrmas-new-drug-ad-rules-still-lack-an-enforcement-mechanism/]]></link>
		<description><![CDATA[PhRMA has published new rules for direct-to-consumer drug advertising. Although the new rules are more strict than the previous ones, they still have one giant hole in them -- enforcement is non existent. Plus, Rep. Henry Waxman D-Calif., just announced that as head of the Committee on Energy and Commerce,...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Wed, 10 Dec 2008 17:06:03 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/advertisement.html"><![CDATA[Advertisement]]></category>
		<category domain="http://resources.bnet.com/topic/health+care.html"><![CDATA[Health Care]]></category>
		<category domain="http://resources.bnet.com/topic/phrma.html"><![CDATA[PhRMA]]></category>
		<category domain="http://resources.bnet.com/topic/health+care+professional.html"><![CDATA[Health Care Professional]]></category>
		<category domain="http://resources.bnet.com/topic/dtc.html"><![CDATA[DTC]]></category>
		<category domain="http://resources.bnet.com/topic/vertical+industries.html"><![CDATA[Vertical Industries]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/benefits.html"><![CDATA[Benefits]]></category>
		<category domain="http://resources.bnet.com/topic/enterprise+software.html"><![CDATA[Enterprise Software]]></category>
		<category domain="http://resources.bnet.com/topic/software.html"><![CDATA[Software]]></category>
		<category domain="http://resources.bnet.com/topic/human+resources.html"><![CDATA[Human Resources]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
	</item>
	<item>
		<title><![CDATA[PhRMA v. Obama: Battle Lines Drawn]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/1000394/phrma-v-obama-battle-lines-drawn/]]></link>
		<description><![CDATA[Before President Obama is even sworn in, the battle lines between PhRMA and the healthcare reformers are already being drawn. The drugmaker's lobbyist group is drawing up a campaign to defeat Obama's healthcare reform ideas even before he has actually proposed any. PhRMA is preparing:  a multimillion-dollar public relations...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Fri, 14 Nov 2008 11:36:18 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/medicare.html"><![CDATA[Medicare]]></category>
		<category domain="http://resources.bnet.com/topic/health+care.html"><![CDATA[Health Care]]></category>
		<category domain="http://resources.bnet.com/topic/phrma.html"><![CDATA[PhRMA]]></category>
		<category domain="http://resources.bnet.com/topic/obama.html"><![CDATA[Obama]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/vertical+industries.html"><![CDATA[Vertical Industries]]></category>
		<category domain="http://resources.bnet.com/topic/benefits.html"><![CDATA[Benefits]]></category>
		<category domain="http://resources.bnet.com/topic/enterprise+software.html"><![CDATA[Enterprise Software]]></category>
		<category domain="http://resources.bnet.com/topic/software.html"><![CDATA[Software]]></category>
		<category domain="http://resources.bnet.com/topic/human+resources.html"><![CDATA[Human Resources]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
		<category domain="http://resources.bnet.com/topic/medicare.html"><![CDATA[Medicare]]></category>
		<category domain="http://resources.bnet.com/topic/health+care.html"><![CDATA[Health Care]]></category>
		<category domain="http://resources.bnet.com/topic/phrma.html"><![CDATA[PhRMA]]></category>
		<category domain="http://resources.bnet.com/topic/obama.html"><![CDATA[Obama]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/vertical+industries.html"><![CDATA[Vertical Industries]]></category>
		<category domain="http://resources.bnet.com/topic/benefits.html"><![CDATA[Benefits]]></category>
		<category domain="http://resources.bnet.com/topic/enterprise+software.html"><![CDATA[Enterprise Software]]></category>
		<category domain="http://resources.bnet.com/topic/software.html"><![CDATA[Software]]></category>
		<category domain="http://resources.bnet.com/topic/human+resources.html"><![CDATA[Human Resources]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
	</item>
	<item>
		<title><![CDATA[Pharma Is Whacking R&D, Too -- Or Is It?]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10006/pharma-is-whacking-rd-too-or-is-it/]]></link>
		<description><![CDATA[The variety of woes afflicting Big Pharma have led to a spate of well-publicized layoffs, mostly among sales forces -- 42,000 since the beginning of 2007, according to one count. Yesterday, Cole Werber at the In Vivo Blog highlighted yet another foreboding statistic: Drugmakers are also starting to trim R&D...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Sat, 12 Apr 2008 12:57:13 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/business+operations.html"><![CDATA[Business Operations]]></category>
		<category domain="http://resources.bnet.com/topic/david+p.+hamilton.html"><![CDATA[David P. Hamilton]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
		<category domain="http://resources.bnet.com/topic/phrma.html"><![CDATA[PhRMA]]></category>
		<category domain="http://resources.bnet.com/topic/r%2526d.html"><![CDATA[R&D]]></category>
		<category domain="http://resources.bnet.com/topic/research+%2526+development.html"><![CDATA[Research & Development]]></category>
		<category domain="http://resources.bnet.com/topic/werber.html"><![CDATA[Werber]]></category>
	</item>
	<item>
		<title><![CDATA[Sharing Miracles Television Program to Feature Emmy Award-Winning Actor Joey Pantoliano]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5554/is_200804/ai_n25312020]]></link>
		<description><![CDATA[To: NATIONAL EDITORS Contact: Kate Michael of PhRMA, +1-202-835-3460  WASHINGTON, April 2, 2008 /PRNewswire-USNewswire/ -- This month, Sharing Miracles - a 30-minute public affairs television program that tells the compelling and inspirational stories of real patients - will feature Joey Pantoliano, an Emmy Award-winning actor, writer and producer who...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 02 Apr 2008 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/abc+inc..html"><![CDATA[ABC Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/cbs+corp..html"><![CDATA[CBS Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/depression.html"><![CDATA[depression]]></category>
		<category domain="http://resources.bnet.com/topic/phrma.html"><![CDATA[PhRMA]]></category>
		<category domain="http://resources.bnet.com/topic/tvs.html"><![CDATA[TVs]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CBS</category>
		<category domain="tickers">CBS</category>
	</item>
	<item>
		<title><![CDATA[PhRMA lobbying spend soared by 25% in 2007]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_qa5351/is_200804/ai_n25420709]]></link>
		<description><![CDATA[PHRMA SPENT more than $22 million lobbying the federal government last year-nearly a 25% increase from the amount spent in 2006, disclosure records filed by the group in February show. According to the records, PhRMA spent $12 million in the second half of 2007 lobbying against efforts, including a bill...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 01 Apr 2008 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/benefits.html"><![CDATA[Benefits]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[HEALTHCARE]]></category>
		<category domain="http://resources.bnet.com/topic/phrma.html"><![CDATA[PhRMA]]></category>
		<category domain="http://resources.bnet.com/topic/software.html"><![CDATA[SOFTWARE]]></category>
		<category domain="http://resources.bnet.com/topic/u.s.+congress.html"><![CDATA[U.S. Congress]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA['Sharing Miracles' Television Program to Feature Mountain Climber and Cancer Survivor Sean Swarner]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5554/is_200803/ai_n25309353]]></link>
		<description><![CDATA[To: RADIO-TELEVISION EDITORS Contact: Kate Michael of the Pharmaceutical Research and Manufacturers of America, +1-202-835-3460  WASHINGTON, March 6 /PRNewswire-USNewswire/ -- This month, Sharing Miracles-- a 30-minute public affairs television program that tells the compelling and inspirational stories of real patients -- will feature Sean Swarner, a two-time cancer survivor...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 06 Mar 2008 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/abc+inc..html"><![CDATA[ABC Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/cbs+corp..html"><![CDATA[CBS Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/patient.html"><![CDATA[patient]]></category>
		<category domain="http://resources.bnet.com/topic/phrma.html"><![CDATA[PhRMA]]></category>
		<category domain="http://resources.bnet.com/topic/tv.html"><![CDATA[TV]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CBS</category>
		<category domain="tickers">CBS</category>
	</item>
	<item>
		<title><![CDATA[New Study Reveals Generic Drugs Continue Entering Market as Competition from Authorized Generics Increases]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5554/is_200704/ai_n21901601]]></link>
		<description><![CDATA[To: HEALTH/MEDICAL EDITORSContact: Jennifer Page of PhRMA, +1-202-835-3460 WASHINGTON, April 19 /PRNewswire-USNewswire/ -- According to a new study by researchers at the Massachusetts Institute of Technology's MIT School of Management and Analysis Group Inc., there is no evidence that the recent increase in prevalence of authorized generics has resulted in...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 19 Apr 2007 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/branding.html"><![CDATA[Branding]]></category>
		<category domain="http://resources.bnet.com/topic/generic.html"><![CDATA[generic]]></category>
		<category domain="http://resources.bnet.com/topic/marketing.html"><![CDATA[MARKETING]]></category>
		<category domain="http://resources.bnet.com/topic/massachusetts+institute+of+technology.html"><![CDATA[Massachusetts Institute of Technology]]></category>
		<category domain="http://resources.bnet.com/topic/phrma.html"><![CDATA[PhRMA]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[The Rudy You Don't Know:]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5554/is_200703/ai_n21890150]]></link>
		<description><![CDATA[To: POLITICAL EDITORSContact: Stacie Paxton or Mark Paustenbach, +1-202-863-8148, both of the Democratic National Committee WASHINGTON, March 15 /PRNewswire-USNewswire/ -- Once again, Rudy Giuliani's business interests and his refusal to divulge a full list of all his businesses' clients are creating a problem for the GOP Presidential hopeful. This is...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 15 Mar 2007 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/bloomberg+l.p..html"><![CDATA[Bloomberg L.P.]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[FINANCE]]></category>
		<category domain="http://resources.bnet.com/topic/financial.html"><![CDATA[financial]]></category>
		<category domain="http://resources.bnet.com/topic/newsday.html"><![CDATA[Newsday]]></category>
		<category domain="http://resources.bnet.com/topic/phrma.html"><![CDATA[PhRMA]]></category>
		<category domain="http://resources.bnet.com/topic/president.html"><![CDATA[president]]></category>
		<category domain="http://resources.bnet.com/topic/u.s..html"><![CDATA[U.S.]]></category>
		<category domain="http://resources.bnet.com/topic/venezuela.html"><![CDATA[Venezuela]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Democratic National Committee: Rudy's Reluctant Candidacy Exposes Controversial Business Dealings]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5554/is_200702/ai_n21888577]]></link>
		<description><![CDATA[To: POLITICAL EDITORSContact: Dag Vega or Karen Finney, +1-202-862-8148, both of the Democratic National Committee WASHINGTON, Feb. 5 /PRNewswire-USNewswire/ -- The following was released today by the Democratic National Committee:  After months of giving non-committal responses to questions about a possible presidential run, Rudy Giuliani today filed his "statement...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 05 Feb 2007 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/federal+election+commission.html"><![CDATA[Federal Election Commission]]></category>
		<category domain="http://resources.bnet.com/topic/newsday.html"><![CDATA[Newsday]]></category>
		<category domain="http://resources.bnet.com/topic/phrma.html"><![CDATA[PhRMA]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[HOUSE OF HEARINGS]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_qa5351/is_200612/ai_n21404355]]></link>
		<description><![CDATA[With the Democrats set to take control of Congress, the new guard of committee leadership presents a mixed-to-bleak picture for pharma industry interests.   Hearings, hearings and more hearings on the dastardly doings of the pharmaceutical industry will be the order of the day for a Democratic Congress, Washington...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Fri, 01 Dec 2006 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/advertisement.html"><![CDATA[advertisement]]></category>
		<category domain="http://resources.bnet.com/topic/agency.html"><![CDATA[agency]]></category>
		<category domain="http://resources.bnet.com/topic/democrat.html"><![CDATA[Democrat]]></category>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/phrma.html"><![CDATA[PhRMA]]></category>
		<category domain="http://resources.bnet.com/topic/rep..html"><![CDATA[Rep.]]></category>
		<category domain="http://resources.bnet.com/topic/sen..html"><![CDATA[Sen.]]></category>
		<category domain="http://resources.bnet.com/topic/strategy.html"><![CDATA[Strategy]]></category>
		<category domain="http://resources.bnet.com/topic/u.s.+senate.html"><![CDATA[U.S. Senate]]></category>
	</item>
	<item>
		<title><![CDATA[AARP keeps finger on Rx prices]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb3235/is_7_23/ai_n29262733]]></link>
		<description><![CDATA[WASHINGTON -- Wholesale drug prices are rising faster than the rate of inflation, according to a report from AARP.  "Prices for brand name drugs have jumped 40% on average over the past six years, compared with inflation of only 17%," says John Rother, AARP director of policy and strategy....]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 24 Apr 2006 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/aarp.html"><![CDATA[AARP]]></category>
		<category domain="http://resources.bnet.com/topic/brand.html"><![CDATA[brand]]></category>
		<category domain="http://resources.bnet.com/topic/branding.html"><![CDATA[Branding]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[FINANCE]]></category>
		<category domain="http://resources.bnet.com/topic/inflation.html"><![CDATA[inflation]]></category>
		<category domain="http://resources.bnet.com/topic/marketing.html"><![CDATA[MARKETING]]></category>
		<category domain="http://resources.bnet.com/topic/phrma.html"><![CDATA[PhRMA]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Fighting counterfeit drugs.(wave length)(using RFID for tracking)]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb4754/is_200506/ai_n17332762]]></link>
		<description><![CDATA[While full implementation of an RFID/EPC system to track and trace  pharmaceutical products from manufacturer to the pharmacy may be some  years away, federal regulators and industry leaders alike believe the  technology offers the best weapon in the     While full implementation of an...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 15 Jun 2005 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/authentication.html"><![CDATA[authentication]]></category>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[pharmaceutical company]]></category>
		<category domain="http://resources.bnet.com/topic/phrma.html"><![CDATA[PhRMA]]></category>
		<category domain="http://resources.bnet.com/topic/rfid.html"><![CDATA[RFID]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Towards Commercial Mobile Ad Hoc Network Applications]]></title>
		<link><![CDATA[http://jobfunctions.bnet.com/abstract.aspx?docid=285284]]></link>
		<description><![CDATA[We propose a novel and plausibly realistic application scenario for mobile ad hoc networks in the form of a radio dispatch system. We evaluate the system from both financial and technical perspectives to gain a complete picture of its feasibility. Using a realistic mobility and propagation model drawn from real...]]></description>
		<s:doctype><![CDATA[White papers]]></s:doctype>
		<pubDate>Wed, 25 May 2005 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/mobile.html"><![CDATA[Mobile]]></category>
		<category domain="http://resources.bnet.com/topic/network.html"><![CDATA[Network]]></category>
		<category domain="http://resources.bnet.com/topic/phrma.html"><![CDATA[PhRMA]]></category>
		<category domain="http://resources.bnet.com/topic/advertising+%2526+promotion.html"><![CDATA[Advertising & Promotion]]></category>
		<category domain="http://resources.bnet.com/topic/networking.html"><![CDATA[Networking]]></category>
		<category domain="http://resources.bnet.com/topic/marketing.html"><![CDATA[Marketing]]></category>
	</item>
	<item>
		<title><![CDATA[Electronic Authentication of Pharmaceutical Packaging and the Assurance of Public Safety: Position of the Pharmaceutical Research and Manufacturers of America]]></title>
		<link><![CDATA[http://jobfunctions.bnet.com/abstract.aspx?docid=159871]]></link>
		<description><![CDATA[This White Paper establishes the position of the Pharmaceutical Research and Manufacturers of America PhRMA on the use of electronic authentication technologies, such as two-dimensional bar codes and radio-frequency identification RFID tags, to secure the U.S. drug supply against counterfeiting threats. PhRMA issues this White Paper to engage patients, trading...]]></description>
		<s:doctype><![CDATA[White papers]]></s:doctype>
		<pubDate>Sun, 15 May 2005 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
		<category domain="http://resources.bnet.com/topic/authentication.html"><![CDATA[Authentication]]></category>
		<category domain="http://resources.bnet.com/topic/phrma.html"><![CDATA[PhRMA]]></category>
		<category domain="http://resources.bnet.com/topic/federal+government.html"><![CDATA[Federal Government]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
	</item>
	<item>
		<title><![CDATA[Exposing Click Fraud]]></title>
		<link><![CDATA[http://jobfunctions.bnet.com/abstract.aspx?docid=161832]]></link>
		<description><![CDATA[Click fraud has recently emerged as a topic of discussion and debate regarding the potential of undermining the pay-per-click revenue model that has made Google and Yahoo the financial success that they are today. While there is little consensus that click fraud will undermine the pay-per- click market, most search...]]></description>
		<s:doctype><![CDATA[White papers]]></s:doctype>
		<pubDate>Tue, 01 Feb 2005 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/click+fraud.html"><![CDATA[Click Fraud]]></category>
		<category domain="http://resources.bnet.com/topic/phrma.html"><![CDATA[PhRMA]]></category>
	</item>
	<item>
		<title><![CDATA[Foreign drugs pose health risks, HHS report says.(News)(Health and Human Services)]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5252/is_200501/ai_n20159320]]></link>
		<description><![CDATA[Byline: RUPAL PAREKH    WASHINGTON-A long-awaited federal report has reignited the debate  on prescription drug reimportation, contending that drugs from abroad  now pose significant health risks, while a safer U.S.  government-regulated importation pro  Byline: RUPAL PAREKH    WASHINGTON-A long-awaited federal report has...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 03 Jan 2005 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/health+care.html"><![CDATA[health care]]></category>
		<category domain="http://resources.bnet.com/topic/phrma.html"><![CDATA[PhRMA]]></category>
		<category domain="http://resources.bnet.com/topic/prescription+drug.html"><![CDATA[prescription drug]]></category>
		<category domain="http://resources.bnet.com/topic/u.s.+department+of+health+and+human+services.html"><![CDATA[U.S. Department of Health and Human Services]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Drug-firm group prescribes Tauzin.(Billy Tauzin )(Brief Article)]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb4895/is_200412/ai_n17973474]]></link>
		<description><![CDATA[WASHINGTON -- Rep. Billy Tauzin (R-La.)--who turned down the role  of Hollywood's top Washington, D.C., lobbyist--last Wednesday was  named president and CEO of the Pharmaceutical Research and Manufacturers  of America PhRMA, a group that represents such drug giants as Merck  & Co. Inc. and Abbott Laboratories....]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 20 Dec 2004 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/abbott+laboratories+inc..html"><![CDATA[Abbott Laboratories Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/chairman.html"><![CDATA[chairman]]></category>
		<category domain="http://resources.bnet.com/topic/job.html"><![CDATA[job]]></category>
		<category domain="http://resources.bnet.com/topic/lans.html"><![CDATA[LANs]]></category>
		<category domain="http://resources.bnet.com/topic/lobbyist.html"><![CDATA[lobbyist]]></category>
		<category domain="http://resources.bnet.com/topic/networking.html"><![CDATA[NETWORKING]]></category>
		<category domain="http://resources.bnet.com/topic/phrma.html"><![CDATA[PhRMA]]></category>
		<category domain="http://resources.bnet.com/topic/u.s.+congress.html"><![CDATA[U.S. Congress]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ABT</category>
		<category domain="tickers">ABT</category>
	</item>
</channel>
</rss>
